ATE71527T1 - Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung. - Google Patents

Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.

Info

Publication number
ATE71527T1
ATE71527T1 AT85850286T AT85850286T ATE71527T1 AT E71527 T1 ATE71527 T1 AT E71527T1 AT 85850286 T AT85850286 T AT 85850286T AT 85850286 T AT85850286 T AT 85850286T AT E71527 T1 ATE71527 T1 AT E71527T1
Authority
AT
Austria
Prior art keywords
production
activating composition
macrophage activating
macrophage
water
Prior art date
Application number
AT85850286T
Other languages
English (en)
Inventor
Karl Olov Peter Larm
James Hoffman
Rolf Seljelid
Jarl Bogwald
Original Assignee
Karl Olov Peter Larm
James Hoffman
Rolf Seljelid
Jarl Bogwald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Olov Peter Larm, James Hoffman, Rolf Seljelid, Jarl Bogwald filed Critical Karl Olov Peter Larm
Application granted granted Critical
Publication of ATE71527T1 publication Critical patent/ATE71527T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85850286T 1984-09-19 1985-09-17 Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung. ATE71527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8404699A SE466289B (sv) 1984-09-19 1984-09-19 Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
EP85850286A EP0175667B1 (de) 1984-09-19 1985-09-17 Macrophage aktivierende Zusammensetzung und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE71527T1 true ATE71527T1 (de) 1992-02-15

Family

ID=20357069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85850286T ATE71527T1 (de) 1984-09-19 1985-09-17 Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (1) US4795745A (de)
EP (1) EP0175667B1 (de)
JP (1) JPH072643B2 (de)
AT (1) ATE71527T1 (de)
DE (1) DE3585193D1 (de)
SE (1) SE466289B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
AU1455292A (en) * 1991-02-01 1992-09-07 Bioglucans, L.P. Soluble glucans
DE4109282A1 (de) * 1991-03-21 1992-09-24 Stihl Maschf Andreas Schneidgeraet, insbesondere fuer graeser
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
US5972717A (en) * 1995-05-10 1999-10-26 The Blood Center Research Foundation, Inc. Method and kit for detecting heparin induced thrombocytopenia
EP0970702A4 (de) * 1996-02-15 2000-01-12 Daiichi Seiyaku Co Faktoren, die das gehirn aktivieren
US5972718A (en) * 1996-02-28 1999-10-26 The Blood Center Research Foundation Method of detecting heparin-induced thrombocytopenia
US5843186A (en) * 1996-12-20 1998-12-01 Implemed, Inc. Intraocular lens with antimicrobial activity
GB2325233B (en) * 1997-05-16 2001-07-18 Norsk Hydro As Substrates having bound polysaccharides and bacterial nucleic acids
SE522410C2 (sv) * 1997-06-06 2004-02-10 Biotec Pharmacon Asa Beta 1-3-glukanderivat med immunomodulerande verkan
MXPA00003108A (es) * 1997-10-03 2001-07-01 Polisacaridos formadores de iminas, preparacion de los mismos y el uso como adyuvantes e inmunoestimulan
GB0112649D0 (en) * 2001-05-24 2001-07-18 Isis Innovation Macrophage receptor
GB0211118D0 (en) * 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
KR100563616B1 (ko) * 2004-05-20 2006-03-22 그린텍이십일 주식회사 베타글루칸 유도체, 그의 제조방법 및 베타글루칸유도체를 이용한 유착방지제, 그의 제조방법
EP2144064A3 (de) 2004-10-04 2010-05-26 Akers Biosciences, Inc. Zusammensetzungen und Verfahren zur Modulation des Lignins einer Pflanze
CN101184780B (zh) * 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
JP2007297322A (ja) * 2006-04-28 2007-11-15 Toyobo Co Ltd サイトカイン産生の促進方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2560532C2 (de) * 1974-11-26 1988-11-10 Takeda Chemical Industries, Ltd., Osaka, Jp
FR2360310A1 (fr) * 1976-08-03 1978-03-03 Ajinomoto Kk Solution antitumorale aqueuse et son procede de preparation
US4156066A (en) * 1977-06-23 1979-05-22 Tyndale Plains - Hunter Ltd. Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone
JPS56115727A (en) * 1980-02-19 1981-09-11 Kuraray Co Ltd Carrier for immobilizing physiologically active substance
JPS5747493A (en) * 1980-09-02 1982-03-18 Fuji Photo Film Co Ltd Method of determining a trace amount of enzyme
JPS5840301A (ja) * 1981-09-03 1983-03-09 Takara Shuzo Co Ltd 抗腫瘍活性を有するβ−1,3−グルカン
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma

Also Published As

Publication number Publication date
JPS61118320A (ja) 1986-06-05
DE3585193D1 (de) 1992-02-27
EP0175667A2 (de) 1986-03-26
JPH072643B2 (ja) 1995-01-18
SE8404699D0 (sv) 1984-09-19
US4795745A (en) 1989-01-03
EP0175667A3 (en) 1986-12-17
SE466289B (sv) 1992-01-27
SE8404699L (sv) 1986-03-20
EP0175667B1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
ATE71527T1 (de) Macrophage aktivierende zusammensetzung und ein verfahren zu ihrer herstellung.
HUT38893A (en) Fungicides containing derivatives of acryl acid and process for production of the reagent
ATE35271T1 (de) Csf und verfahren zu seiner herstellung.
ATE5782T1 (de) Bogenzusammenstellung und verfahren zu deren herstellung.
DE68910654D1 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung.
HUT38262A (en) Process for production of slowly releasing compositions
DE3883408D1 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
ATE83605T1 (de) Pestizide zusammensetzungen und verfahren zu ihrer herstellung.
DE3888585D1 (de) Klebstoffzusammensetzung für Fasermaterial und Verfahren zu ihrer Herstellung.
DE69308531D1 (de) Cycloisomaltooligosaccharide; Enzym und Verfahren zu ihrer Herstellung, und Verfahren zur Herstellung von dem Enzym
ATE62480T1 (de) Aminoalkohol-derivate und verfahren zu ihrer herstellung.
ATE11523T1 (de) Kalk-kieselsaeure-masse hoher porositaet und verfahren zu deren herstellung.
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
ATE51875T1 (de) Chemisches verfahren zur herstellung von antibiotikum l 17043.
HUT39073A (en) Insecticides containing as reagent derivatives of pirazolin and process for production of the reagent
HUT48795A (en) Acarycides containing 2,3-diamin malein acid nitril azomethin and process for production of these compositions
DE3781350D1 (de) Angefeuchtete zusammensetzungen von hydratbildenden phosphaten und verfahren zu deren herstellung.
DE3850891D1 (de) Verfahren zur Herstellung von hochtemperaturbeständigen Polymerisaten in Pulverform sowie Anlage zur Durchführung des Verfahrens.
HUT39432A (en) Plant protection preparatives containg as reagent 2,4-diamino-6-halogene-5-alkyltio-piramidins and process for production of the reagent
ATE103899T1 (de) Zwischenprodukte und verfahren zu ihrer herstellung.
HUT36339A (en) Fungicides containing substituted azolile-tetrahydro-furane-2-ilidene-methane-derivatives as agent and process for the production of substituted azolile-tetrahydro-furano-2-ilidene-methane-derivatives
HUT36330A (en) Pesticide preparatives and process for production of the utilized as reagent derivatives of 4-pentin acid
ATE10492T1 (de) Stabile peroxydzusammensetzung und verfahren zu ihrer herstellung.
ATE101396T1 (de) N-glykoneuraminsaeure enthaltendes glykolipid und verfahren zu dessen herstellung.
ATE78493T1 (de) Amphoterische staerke und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee